Education
About Us
Working with TipRanks
Follow Us
Biomx Inc. (PHGE)
:PHGE
PHGE Stock Chart & Stats
$0.59
-$0.09(-11.33%)
At close: 4:00 PM EST
$0.59
-$0.09(-11.33%)
Day’s Range― - ―
52-Week Range$0.34 - $1.16
Previous CloseN/A
Volume30.96K
Average Volume (3M)355.85K
Market Cap
$15.56M
Enterprise Value$27.08M
Total Cash (Recent Filing)$14.05M
Total Debt (Recent Filing)$9.38M
Price to Earnings (P/E)―
Beta0.80
Next Earnings
Nov 13, 2025EPS Estimate
-0.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.19
Shares Outstanding26,554,888
10 Day Avg. Volume377,629
30 Day Avg. Volume355,849
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.74
Enterprise Value/Revenue-322.44
Enterprise Value/Gross Profit-16.09
Enterprise Value/Ebitda-1.93
Forecast
1Y Price Target
$15.00Price Target Upside2442.37% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bulls Say, Bears Say
Bulls Say
Regulatory PathwayThe company plans to meet with the FDA to discuss data collected on real-world evidence in CF patients, which could potentially streamline an approval pathway.
Trial ResultsBiomX recently announced positive topline results from the Phase 2 trial of BX211 for diabetic foot osteomyelitis.
Bears Say
Clinical Trial HoldA clinical hold was placed on the Phase 2 CF trial due to nebulizer safety concerns, but not related to BX004 as a clinical or product candidate.
BiomX News
PHGE FAQ
What was Biomx Inc.’s price range in the past 12 months?
Biomx Inc. lowest stock price was $0.34 and its highest was $1.16 in the past 12 months.
What is Biomx Inc.’s market cap?
Biomx Inc.’s market cap is $15.56M.
When is Biomx Inc.’s upcoming earnings report date?
Biomx Inc.’s upcoming earnings report date is Nov 13, 2025 which is in 20 days.
How were Biomx Inc.’s earnings last quarter?
Biomx Inc. released its earnings results on Aug 13, 2025. The company reported -$0.19 earnings per share for the quarter, beating the consensus estimate of -$0.26 by $0.07.
Is Biomx Inc. overvalued?
According to Wall Street analysts Biomx Inc.’s price is currently Undervalued.
Does Biomx Inc. pay dividends?
Biomx Inc. does not currently pay dividends.
What is Biomx Inc.’s EPS estimate?
Biomx Inc.’s EPS estimate is -0.3.
How many shares outstanding does Biomx Inc. have?
Biomx Inc. has 26,554,888 shares outstanding.
What happened to Biomx Inc.’s price movement after its last earnings report?
Biomx Inc. reported an EPS of -$0.19 in its last earnings report, beating expectations of -$0.26. Following the earnings report the stock price went down -10.714%.
Which hedge fund is a major shareholder of Biomx Inc.?
Currently, no hedge funds are holding shares in PHGE
Company Description
Biomx Inc.
BiomX Inc. (PHGE) is a clinical-stage microbiome company that focuses on the discovery and development of bacteriophage-based therapies. These therapies are designed to target and destroy harmful bacteria in the human body, particularly in diseases where the microbiome plays a significant role. The company's core products are aimed at conditions such as acne, inflammatory bowel disease (IBD), and primary sclerosing cholangitis (PSC), leveraging its proprietary microbiome discovery platform to identify and develop phage therapies.
PHGE Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
BiomX demonstrated significant progress in its clinical pipeline, particularly with the initiation of the BX004 Phase IIb trial and positive validation from published studies. However, financial challenges were evident with a decrease in cash balance and a reported net loss, offset by cost reductions. The sentiment reflects a balanced outlook with strong clinical momentum but financial caution.View all PHGE earnings summariesPHGE Stock 12 Month Forecast
Average Price Target
$15.00
▲(2442.37% Upside)
Technical Analysis
Ownership Overview
10.46% Insiders
31.93% Other Institutional Investors
57.61% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---